Gene · 23607
Papers1,907
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,907
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CRISPR in Alzheimer's Disease: Engineering Genetic Solutions for Neurodegenerative Resilience. | Curr Neuropharmacol | 2026 | 41568513 | PubTator, text mining | PubMed |
| Olink Proteomic Profiling of Vitreous Humor and Plasma From Proliferative Diabetic Retinopathy Patients Identifies a Novel Inflammatory Molecular Endotype. | Invest Ophthalmol Vis Sci | 2026 | 41563014 | PubTator, text mining | PubMed |
| Slit Diaphragm Molecular Changes in Recurrent FSGS With Antinephrin Autoantibodies. | Kidney Int Rep | 2026 | 41502813 | PubTator, text mining | PubMed |
| Sex-aware causal inference assessment of the immune system in complex neurodegenerative diseases. | Brain | 2026 | 41437896 | PubTator, text mining | PubMed |
| Microglial phagocytosis in Alzheimer disease. | Nat Rev Neurol | 2026 | 41315858 | PubTator, text mining | PubMed |
| Structural and functional insights of the podocyte slit diaphragm complex. | Tissue Barriers | 2026 | 41100809 | PubTator, text mining | PubMed |
| Association between Urinary Copper and Gestational Diabetes Mellitus: Role of Epigenome-Wide DNA Methylation and Proteomics. | J Clin Endocrinol Metab | 2026 | 41052303 | PubTator, text mining | PubMed |
| Mass Spectrometry of Minimal Change Disease and Focal Segmental Glomerulosclerosis. | Kidney Int Rep | 2025 | 41426026 | PubTator, text mining | PubMed |
| Identification of a ubiquitin-binding domain protein, CD2AP, in predicting the prognosis and treatment of lung adenocarcinoma. | Front Immunol | 2025 | 41425578 | PubTator, text mining | PubMed |
| Genetic and environmental factors associated with alteration of filtration slit proteins and their functions: a scoping review. | Front Nephrol | 2025 | 41368354 | PubTator, text mining | PubMed |
| CD2AP is a disulfidptosis modulator and prognostic biomarker in hepatocellular carcinoma. | Clin Exp Med | 2025 | 41249753 | PubTator, text mining | PubMed |
| Modelling APOL1-mediated kidney inflammation and fibrosis using a partially reprogrammed urine-derived SIX2-positive renal progenitor cell line. | Stem Cell Res Ther | 2025 | 41225540 | PubTator, text mining | PubMed |
| The MYO1F interactome reveals ASAP1, CD2AP and SH3KBP1 as novel adaptor proteins in podosomes and phagosomes. | J Cell Sci | 2025 | 41208482 | PubTator, text mining | PubMed |
| Integration of Single-cell and bulk RNA sequencing data uncovers lymphatic metastasis-related prognostic genes and a predictive model in bladder cancer. | Sci Rep | 2025 | 41198839 | PubTator, text mining | PubMed |
| Exosomes and Renal Fibrosis: Diagnostic Value, Therapeutic Potential and Challenges. | Int J Nanomedicine | 2025 | 40969664 | PubTator, text mining | PubMed |
| Integration of urine retinol-binding protein and genetic markers for early prediction of tacrolimus nephrotoxicity using machine learning. | Transl Pediatr | 2025 | 40949902 | PubTator, text mining | PubMed |
| G-quadruplex-dependent transcriptional regulation by molecular condensation in the Bcl3 promoter. | Nucleic Acids Res | 2025 | 40884402 | PubTator, text mining | PubMed |
| Ras and Rab interactor 3 as a prognostic biomarker and its impact on immune cell infiltration in cancer. | Sci Rep | 2025 | 40830225 | PubTator, text mining | PubMed |
| CIN85 and CD2AP Are Novel Constituents of Dynamic Tubular Recycling Endosomes That Regulate Recycling Upon Recruitment by MICAL-L1. | Traffic | 2025 | 40740057 | PubTator, text mining | PubMed |
| Disulfidptosis-Related Genes as Novel Biomarkers and Therapeutic Targets in Dilated Cardiomyopathy. | J Inflamm Res | 2025 | 40735269 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23607/papers?page=2